Is HFNC noninferior to NIV for Acute Respiratory Failure?

January 24, 2025 00:31:44
Is HFNC noninferior to NIV for Acute Respiratory Failure?
Critical Care Perspectives in Emergency Medicine
Is HFNC noninferior to NIV for Acute Respiratory Failure?

Jan 24 2025 | 00:31:44

/

Show Notes

Both NIV and HFNC are used to treat patients with acute respiratory failure.  Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema.  However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.

Other Episodes

Episode

December 29, 2023 00:24:55
Episode Cover

Should We Intubate For GCS < 8?

Acute mental status changes after the ingestion of alcohol or other substances are a common presentation to the ED.  Those with severe obtundation may...

Listen

Episode 0

October 23, 2017 00:30:25
Episode Cover

An Approach to Refractory Hypoxemia

The use of a PEEP recruitment maneuver is common among ventilated patients with refractory hypoxemia.  However, a recent JAMA study questions whether we should...

Listen

Episode 0

September 27, 2021 00:25:40
Episode Cover

Milrinone or Dobutamine for Cardiogenic Shock?

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data...

Listen